Prognostic Impact of 21-Gene Recurrence Score in Patients With Stage IV Breast Cancer: TBCRC 013 Academic Article uri icon

Overview

MeSH Major

  • Breast Neoplasms
  • Neoplasm Recurrence, Local

abstract

  • The 21-gene RS is independently prognostic for both TTP and 2-year OS in ER-positive/HER2-negative de novo stage IV breast cancer. Prospective validation is needed to determine the potential role for this assay in the clinical management of this patient subset.

publication date

  • July 10, 2016

Research

keywords

  • Academic Article

Identity

Language

  • eng

PubMed Central ID

  • PMC4981976

Digital Object Identifier (DOI)

  • 10.1200/JCO.2015.63.1960

PubMed ID

  • 27001590

Additional Document Info

start page

  • 2359

end page

  • 65

volume

  • 34

number

  • 20